We’re in the News: Stay informed of Noble in the news as we advance our mission to create advanced drug delivery system trainers for the world’s leading pharmaceutical companies, which, in the end, benefit millions of patients worldwide.
Packaging Accessory Boosts Usability of Pharma Autoinjector
A new grip-able sleeve for pharmaceutical autoinjector pens makes it easier for patients with reduced dexterity due to rheumatoid arthritis (RA) to handle the medical device and perform self-injections, which can help improve health [...]
Drug Delivery Training Devices That Help Patients Learn To Administer Their Injection Medications
Joe Reynolds leverages the knowledge of the pharmaceutical and medical device industries to derive insights and maximize value for all members of the Noble healthcare team. His experience includes work with various consumer and [...]
Gaps in Training, Poor Adherence Highlight Need For Gastroenterologists To Demand Improved Onboarding Tools
Desperate for relief, many people living with inflammatory bowel disease (IBD)—either Crohn’s disease or ulcerative colitis—rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting task—evidenced by the 45% [...]
Training Diabetes Patients on Self-Injection Is Essential
Ensuring that diabetes patients correctly administer their insulin or glucagon is a priority for prescribers and patients alike. Keeping tabs on the extent to which patients are (or are not) taking their medications as [...]
Training Devices Increase Patient Engagement and Adherence – Creating Better Outcomes
Across the US, half of all adults live with a chronic disease – and many of them are prescribed a self-injectable therapy to help manage their condition. As the patient population and demand for [...]
Gaps in Training, Poor Adherence Highlight Need For Dermatologists To Demand Improved Onboarding Tools
Desperate for relief, many people living with psoriasis and atopic dermatitis rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting task—evidenced by the 45% of patients who skip [...]